FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
9.88
+0.63 (6.81%)
At close: Aug 13, 2025, 4:00 PM
9.87
-0.01 (-0.10%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
FibroGen Market Cap
FibroGen has a market cap or net worth of $39.95 million as of August 14, 2025. Its market cap has decreased by -64.13% in one year.
Market Cap
39.95M
Enterprise Value
109.72M
1-Year Change
-64.13%
Ranking
Category
Stock Price
$9.88
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $39.95M, a decrease of -96.74%. That is a compound annual growth rate of -27.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 40.00M | -25.09% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |